These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38680552)

  • 1. Dose-response evaluation of intravenous gene therapy in a symptomatic mouse model of metachromatic leukodystrophy.
    Audouard E; Khefif N; Mansat C; Nelcha O; Banchi EG; Lupiet C; Farabos D; Lamaziere A; Sevin C; Piguet F
    Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101248. PubMed ID: 38680552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Correction of Brain and Spinal Cord Pathology in Metachromatic Leukodystrophy Mice.
    Audouard E; Oger V; Meha B; Cartier N; Sevin C; Piguet F
    Front Mol Neurosci; 2021; 14():677895. PubMed ID: 34093126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype? - Chances and challenges.
    Santhanakumaran V; Groeschel S; Harzer K; Kehrer C; Elgün S; Beck-Wödl S; Hengel H; Schöls L; Haack TB; Krägeloh-Mann I; Laugwitz L
    Mol Genet Metab; 2022 Nov; 137(3):273-282. PubMed ID: 36240581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.
    Piguet F; Sondhi D; Piraud M; Fouquet F; Hackett NR; Ahouansou O; Vanier MT; Bieche I; Aubourg P; Crystal RG; Cartier N; Sevin C
    Hum Gene Ther; 2012 Aug; 23(8):903-14. PubMed ID: 22642214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access.
    Fumagalli F; Calbi V; Natali Sora MG; Sessa M; Baldoli C; Rancoita PMV; Ciotti F; Sarzana M; Fraschini M; Zambon AA; Acquati S; Redaelli D; Attanasio V; Miglietta S; De Mattia F; Barzaghi F; Ferrua F; Migliavacca M; Tucci F; Gallo V; Del Carro U; Canale S; Spiga I; Lorioli L; Recupero S; Fratini ES; Morena F; Silvani P; Calvi MR; Facchini M; Locatelli S; Corti A; Zancan S; Antonioli G; Farinelli G; Gabaldo M; Garcia-Segovia J; Schwab LC; Downey GF; Filippi M; Cicalese MP; Martino S; Di Serio C; Ciceri F; Bernardo ME; Naldini L; Biffi A; Aiuti A
    Lancet; 2022 Jan; 399(10322):372-383. PubMed ID: 35065785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
    Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
    Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotype and LRP1 polymorphisms in patients with different clinical types of metachromatic leukodystrophy.
    Ługowska A; Musielak M; Jamroz E; Pyrkosz A; Kmieć T; Tylki-Szymańska A; Bednarska-Makaruk M
    Gene; 2013 Sep; 526(2):176-81. PubMed ID: 23701968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atidarsagene autotemcel for metachromatic leukodystrophy.
    Messina M; Gissen P
    Drugs Today (Barc); 2023 Feb; 59(2):63-70. PubMed ID: 36811406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme, cell and gene-based therapies for metachromatic leukodystrophy.
    Sevin C; Aubourg P; Cartier N
    J Inherit Metab Dis; 2007 Apr; 30(2):175-83. PubMed ID: 17347913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A.
    Miyake N; Miyake K; Sakai A; Yamamoto M; Suzuki H; Shimada T
    Sci Rep; 2021 Oct; 11(1):20513. PubMed ID: 34654893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
    Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
    Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Systemic Administration of a Gene Therapy Leading to Disease Treatment in Metachromatic Leukodystrophy
    St Martin T; Seabrook TA; Gall K; Newman J; Avila N; Hayes A; Kivaa M; Lotterhand J; Mercaldi M; Patel K; Rivas IJ; Woodcock S; Wright TL; Seymour AB; Francone OL; Gingras J
    J Neurosci; 2023 May; 43(19):3567-3581. PubMed ID: 36977578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the Therapeutic Utility of Olaparib in Sulfatide-Induced Human Astrocyte Toxicity and Neuroinflammation.
    Mekhaeil M; Conroy MJ; Dev KK
    J Neuroimmune Pharmacol; 2023 Dec; 18(4):592-609. PubMed ID: 37924373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective.
    Beerepoot S; Nierkens S; Boelens JJ; Lindemans C; Bugiani M; Wolf NI
    Orphanet J Rare Dis; 2019 Nov; 14(1):240. PubMed ID: 31684987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing therapeutic approaches for metachromatic leukodystrophy.
    Patil SA; Maegawa GH
    Drug Des Devel Ther; 2013; 7():729-45. PubMed ID: 23966770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Intravenous and Intrathecal Delivery of AAV9-Mediated ARSA in Minipigs.
    Mullagulova A; Shaimardanova A; Solovyeva V; Mukhamedshina Y; Chulpanova D; Kostennikov A; Issa S; Rizvanov A
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olaparib Attenuates Demyelination and Neuroinflammation in an Organotypic Slice Culture Model of Metachromatic Leukodystrophy.
    Mekhaeil M; Conroy MJ; Dev KK
    Neurotherapeutics; 2023 Sep; 20(5):1347-1368. PubMed ID: 37525026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates.
    Zerah M; Piguet F; Colle MA; Raoul S; Deschamps JY; Deniaud J; Gautier B; Toulgoat F; Bieche I; Laurendeau I; Sondhi D; Souweidane MM; Cartier-Lacave N; Moullier P; Crystal RG; Roujeau T; Sevin C; Aubourg P
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):113-24. PubMed ID: 25758611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Novel Arylsulfatase A (
    Xu L; Zhong M; Wang Y; Wang Z; Song J; Zhao J; Yu H; Yang Z; Yan W; Zheng X
    Front Neurol; 2020; 11():576881. PubMed ID: 33505345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A closer look at ARSA activity in a patient with metachromatic leukodystrophy.
    Doherty K; Frazier SB; Clark M; Childers A; Pruthi S; Wenger DA; Duis J
    Mol Genet Metab Rep; 2019 Jun; 19():100460. PubMed ID: 30828547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.